Effect of anaesthetic agents on the synthesis and disappearance of brain dopamine normally and after haloperidol, Kcl or axotomy.
D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001369:Axons / Q000502:physiology; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000096:biosynthesis* / Q000378:metabolism; D005246:Feedback; D006220:Haloperidol / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D006221:Halothane / Q000494:pharmacology*; D006834:Hydrazines / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009411:Nerve Endings / Q000187:drug effects; D010424:Pentobarbital / Q000494:pharmacology*; D011189:Potassium Chloride / Q000494:pharmacology*; D051381:Rats; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D006834:Hydrazines; D008781:Methyltyrosines; D004295:Dihydroxyphenylalanine; D011189:Potassium Chloride; D014446:Tyrosine 3-Monooxygenase; D010424:Pentobarbital; D006220:Haloperidol; D006221:Halothane; D004298:Dopamine